Xspray Pharma has now completed the population pharmacokinetic (PopPK) modeling that constitutes key regulatory documentation ...

OncoZenge AB (publ) ("OncoZenge" or "the Company") today announces receipt of the initial investment capital from Sichuan Yangtian Bio-Pharmaceutical Co., Ltd. (the "Investor"). On January 27, 2025, ...

Pharmaceutical and personal care products (PPCPs) have been the focus of increasing concern in recent decades due to their ubiquity in the environment and potential risks. Out-of-date PPCPs are ...

UPPSALA, SE / ACCESS Newswire / July 8, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ.) invites investors, analysts, and media to a webcast presentation of the second quarter report for ...

OncoZenge Appoints Tuulikki Lindmark as Head of CMC in Phase 3 Sponsor TeamOncoZenge AB (publ) ("OncoZenge" or "the Company") announces today that the sponsor team for the phase 3 project with ...